Requirement of caspase-3 for efficient apoptosis induction and caspase-7 activation but not viral replication or cell rounding in cells infected with vesicular stomatitis virus

Human Immunology

Volumn 64, Issue 1, 2003, Pages 82-92

  Hobbs, Jacqueline A ^a   Hommel Berrey, Grace ^a   Brahmi, Zacharie ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Caspase 3; Caspase 7; MCF 7 cells; VSV

Indexed keywords

CASPASE 3; CASPASE 7;

APOPTOSIS; ARTICLE; CELL STRAIN MCF 7; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME DEGRADATION; HOST CELL; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VESICULAR STOMATITIS VIRUS; VIRUS INFECTION; VIRUS REPLICATION;

APOPTOSIS; CASPASE 3; CASPASE 7; CASPASES; ENZYME ACTIVATION; FEMALE; HUMANS; TUMOR CELLS, CULTURED; VESICULAR STOMATITIS-INDIANA VIRUS; VIRUS REPLICATION;

EID: 12244313413     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(02)00702-4     Document Type: Article

References (49)

1. Kerr JFR, Wyllie AM, Currie AR: Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26:239, 1972.
2. Wyllie AH, Kerr JFR, Currie AR: Cell death: the significance of apoptosis. Int Rev Cytol 68:251, 1980.
3. Thornberry NA, Lazebnik V: Caspases: enemies within. Science 281:1312, 1998.
4. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA, Munday NA, Raju SM, Smulson ME, Yamin TT, Yu VL, Miller DK: Identification and inhibition of the ICE/ccd-3 protease necessary for mammalian apoptosis. Nature 376:37, 1995.
5. Vincenz C, Dixit VM: Fas-associated death domain protein interleukin-1β-converting enzyme 2 (FLICE2), and ICE/Ced-3 homologue, is proximally involved in CD95-and p55-mediated death signaling. J Biol Chem 272:6578, 1997.
6. Oberhammer F, Wilson JW, Dive C, Morris ID, Hickman JA, Wakeling AE, Walker PR, Sikorska M: Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J 12:3679, 1993.
7. Sakahira H, Enari M, Nagata S: Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature 391:96, 1998.
8. Liu X, Zou H, Slaughter C, Wang X: DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell 89:175, 1997.
9. Tewari M, Quan LT, O'Rourke K, Desnoyers S, Zeng Z, Beidler DR, Poirier GG, Salvesen GS, Dixit VM: YAMA/ CPP32-β, a mammalian homolog of Ced3, is a CrmA-inhibitable protease that cleaves the death substrate poly (ADP-ribose) polymerase. Cell 81:801, 1995.
10. Orth K, Chinnaiyan AM, Gang M, Froelich CJ, Dixit VM: The CED3-ICE like protease Mch2 is activated during apoptosis and cleaves the death substrate lamin. AJ Biol Chem 271:16443, 1996.
11. Takahashi A, Alnemri ES, Lazebnik VA, Fernandes-Alnemri T, Litwack G, Moir R, Goldman D, Poirier GG, Kaufmann SH, Earnshaw WC: Cleavage of lamin A by Mch2 alpha but not CPP32: multiple interleukin 1 beta-converting enzyme-related proteases with distinct substrate recognition properties are active in apoptosis. Proc Natl Acad Sci USA 93:8395, 1996.
12. Perry DK, Smyth MJ, Wang HG, Reed JC, Duriez P, Poirier GG, Obeid LM, Hannun VA: Bcl-2 acts upsteam of the PARP protease and prevents its activation. Cell Death Differentation 4:29, 1997.
13. Xiang J, Chao DT, Korsmeyer SJ: BAX-induced cell death may not require interleukin- 1β-converting enzyme-like proteases. Proc Natl Acad Sci USA 93:14559, 1996.
14. Sheikh MS, Antinore MJ, Huang Y, Fornace Jr AJ: Ultraviolet-irradiation-induced apoptosis is mediated via ligand independent activation of tumor necrosis factor receptor 1. Oncogene 17:2555, 1998.
15. Montenarh M: Marker genes for cytotoxic exposure. Stem Cells 13:53-136, 1995.
16. Teodoro JG, Branton PE: Regulation of apoptosis by viral gene products. J Virol 71:1739, 1997.
17. Summerfield A, Knötig SML, McCullough KC: Lymphocyte apoptosis during classical swine fever: implication of activation-induced cell death. J Virol 72:1853, 1998.
18. Carthy CM, Granville DJ, Watson KA, Anderson DR, Wilson JE, Yang D, Hunt DWC, McManus BM: Caspase activation and specific cleavage of substrates after coxsackie virus B3-induced cytopathic effect on HeLa cells. J Virol 72:7669, 1998.
19. Sieg S, Kaplan D: Role of the Fas/Fas ligand apoptotic pathway in human immuno- deficiency virus type 1 disease. J Virol 72:6279, 1998.
20. Olsen CW, Kehren JC, Dybdahl-Sissoko N, Hinshaw VS: Bcl-2 alters influenza virus yield, spread, and hemagglutinin glycosylation. J Virol 70:663, 1996.
21. Fesq II, Backer M, Nain M, Gemsa D: Programmed cell death (apoptosis) in human monocytes infected by influenza A virus. Immunobiology 190:175, 1994.
22. Hinshaw VS, Olsen CW, Dybdahl-Sissoko N, Evans D: Apoptosis: a mechanism of cell killing by influenza A and B viruses. J Virol 68:3667, 1994.
23. Takizawa T, Shigeru M, Higuchi Y, Nakamura S, Nakanishi Y, Fukuda R: Induction of programmed cell death (apoptosis) by influenza virus infection in tissue culture cells. J Gen Virol 74:2347, 1993.
24. McQuaid S, McMahon J, Herron B, Cosby SL: Apoptosis in measles virus-infected human central nervous system tissues. Neuropathol Appl Neurobiol 23:218, 1997.
25. Esolen LM, Park SW, Hardwick JM, Griffin DE: Apoptosis is a cause of death in measles virus-infected cells. J Virol 69:3955, 1995.
26. Hobbs JA, Schlemer RS, Hommel-Berrey GA, Brahmi Z: Caspase-3 like proteases are activated by infection but are not required for replication of vesicular stomatis virus. Virus Res 80:53, 2001.
27. Hommel-Berrey GA, Bochan MR, Montel AH, Goebel WS, Froelich CJ, Brahmi Z: Granzyme B independently of perforin mediates noncytolytic intracellular inactivation of vesicular stomatitis virus. Cell Immunol 180:1, 1997.
28. Koyama AH: Induction of apoptotic DNA fragmentation by the infection of vesicular stomatis virus. Virus Res 37:285, 1995.
29. Bi Z, Quandt P, Komatsu T, Barna M, Reiss CS: IL-12 promotes enhanced recovery from vesicular stomatitis virus infection of the central nervous system. J Immunol 155:5684, 1995.
30. Evan G, Littlewood T: A matter of life and cell death. Science 281:1317, 1998.
31. Moffatt S, Yaegashi N, Tada K, Tanaka N, Sugamura K: Human parvovirus B19 nonstructural (NS1) protein induces apoptosis in erythroid lineage cells. J Virol 72: 3018, 1998.
32. Rayet B, Lopez-Guerro JA, Rommelaere J, Dinsart C: Induction of programmed cell death by parvovirus H-1 in U937 cells: connection with the tumor necrosis factor alpha-signaling pathway. J Virol 72:8893, 1998.
33. Micheau O, Lens S, Gaide O, Alevezopoulos K, Tschopp J: NF-kappa B signals induce the expression of c-FLIP. Mol Cell Biol 21:5299, 2001.
34. Deveraux QL, Reed JC: IAP family proteins-suppressors of apoptosis. Genes Dev 13:239, 1999.
35. Gottlieb E, Vander Heiden MG, Thompson CB: Bcl-x(L) prevents the initial decrease in mitochondrial membrane potential and subsequent reactive oxygen species production during tumor necrosis factor alpha-induced apoptosis. Mol Cell Biol 20:5680, 2000.
36. Koyama AH, Arkawa T, Adachi A: Acceleration of virus-induced apoptosis by tumor necrosis factor. FEBS Lett 426:179, 1998.
37. Montel AH, Hommel-Berrey GA, Brahmi Z: Fas-mediated cytotoxicity induces degradation of vesicular stomatitis virus RNA transcripts and reduces viral titer. Mol Immunol 34:1055, 1997.
38. Meinl E, Fickenscher H, Thome M, Tschopp J, Fleckenstein B: Anti-apoptotic strategies of lymphotropic viruses. Immunol Today 19:474, 1998.
39. Thomas D, Newcomb WW, Brown JC, Wall JS, Hainfeld JE, Trus BL, Stevens AD: Mass and molecular composition of vesicular stomatitis virus: a scanning transmission electron microscopy analysis. J Virol 54:598, 1985.
40. Lyles DS, McKenzie MO: Activity of vesicular stomatitis virus M protein mutants in cell rounding is correlated with the ability to inhibit host gene expression and is not correlated with virus assembly function. Virology 229:77, 1997.
41. Black BL, Lyles DS: Vesicular stomatitis virus matrix protein inhibits host cell-directed transcription of target genes in vivo. J Virol 66:4058, 1992.
42. Wagner RR: Rhabdovirus biology and infection: an overview. In: Wagner RR (ed): The rhahdoviruses. New York: Plenum Press, 1987.
43. Ye Z, Sun W, Suryanarayana K, Justice P, Robinson D, Wagner RR: Membrane-binding domains and cytopathogenesis of the matrix protein of vesicular stomatitis virus. J Virol 68:7386, 1994.
44. Blondel D, Harmison GG, Schubert M: role of matrix protein in cytopathogenesis of vesicular stomatitis virus. J Virol 64:1716, 1990.
45. Villa P, Kaufmann SH, Earnshaw WC: Caspases and caspase inhibitors. TIBS 22:388, 1997.
46. Orth K, O'Rourke K, Salvesen GS, Dixit VM: Molecular ordering of apoptotic mammalian CED-3/ICE-like proteases. J Biol Chem 271:20977, 1996.
47. Janicke RU, Ng P, Sprengart ML, Porter AG: Caspase-3 is required for alphafodrin cleavage but dispensable for cleavage of other cell substrates in apoptosis. J Biol Chem 273:15540, 1998.
48. Krajewska NI, Wang II G, Krajewski S, Zapata JM, Shabaik A, Gascoyne I, Reed JC: Immunohistochemical analysis of in vitro patterns of expression of CPP32 (caspase-3), a cell death protease. Cancer Res 57:1605, 1997.
49. Estoppey SI, Rodriguez R, Sadoul R, Martinou JC: Bcl-2 prevents activation of CPP32 cysteine protease and cleavage of poly (ADP-ribose) polymerase and U1-70 kD proteins in staurosporine-mediated apoptosis. Cell Death Differentiation 4:34, 1997.